Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3863_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
11 Мб
Скачать
☆
Chapter 18
Interventional Treatment ofThyroid Nodules
AuhWhanPark, TimHuber, andJungHwanBaek
Current Practice onThyroid Nodules
High-resolution ultrasound (US) detects thyroid nodules in 19–68% of healthy, asymptomatic individuals [1, 2]. The clinical importance of thyroid nodules is to exclude thyroid cancer occurring in 5–15% among the detected thyroid nod­ules [3, 4].
In the 2015 American Thyroid Association (ATA) Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer [5], an algorithm for evaluation and management of patients with thyroid nodules bases on US pattern and ne-needle aspiration (FNA) cytology was suggested. Three main steps exit for workups in the algorithm.
A. W. Park (*) Department of Radiology, University of Virginia Health System, Charlottesville, VA, USA
T. Huber Dotter Department of Interventional Radiology, Oregon Health and Science University, Portland, OR, USA e-mail: huberti@ohsu.edu
J. H. Baek Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
Switzerland AG 2022 H. Yu et al. (eds.), Diagnosis and Management of Endocrine Disorders in Interventional Radiology, https://doi.org/10.1007/978-3-030-87189-5_18
259© The Author(s), under exclusive license to Springer Nature
260
• Suspected thyroid nodule TSH level
TSH
• Pattern
• Size
US
• Cytologic bethesda system
FNA
A. W. Park et al.
A summary of essential recommendations from the ATA guidelines is as follows.
Workups
Serum Thyroid Stimulation Hormone (TSH)
Serum TSH should be measured during the initial evaluation of a patient with a thyroid nodule (Table18.1). If the serum TSH is subnormal, a radionuclide (prefer-
123
ably
I) thyroid scan should be performed. If the serum TSH is normal or elevated,
a radionuclide scan should not be performed as the initial imaging evaluation.
Thyroid Sonography
Thyroid sonography with a survey of the cervical lymph nodes should be performed in all patients with known or suspected thyroid nodules. FNA is the procedure of choice in the evaluation of thyroid nodules when clinically indicated. Thyroid nod­ule diagnostic FNA is recommended (Table 18.2). Thyroid nodules should be assessed for malignancy risk by ATA sonographic risk pattern, not simply by size. Not every thyroid nodule >1cm needs ne-needle aspiration (FNA), and most nod­ule <1cm does not need FNA.
Table 18.1 Evaluation on thyroid stimulation hormone (TSH) with a thyroid nodule
Suspected thyroid nodule TSH: normal or elevated TSH: subnormal Thyroid/neck sonography Radionuclide (preferably
123
I) thyroid scan
18 Interventional Treatment ofThyroid Nodules
Table 18.2 Sonographic patterns, estimated risk of malignancy, and ne-needle aspiration guidance for thyroid nodules
Thyroid/neck sonography High
suspicion
FNA≥1cm FNA≥1.5cm FNA≥2cm FNA not required
Table 18.3 American College of Radiology (ACR) Thyroid Imaging, Reporting and Data System (TI-RADS)
Composition (choose 1)
Cystic or almost completely cystic
Spongiform 0 Hyperechoic 1 Taller than
Cystic and solid
Solid or almost completely solid
Add points from all categories to determine TI-RADS level
0 points 2 points 3 points 4 points 5 points
TR1 TR 2 TR 3 TR 4 TR 5
Benign Not suspicious Mildly
No FNA No FNA FNA if
Intermediate suspicion
Echogenicity (choose 1)
0 Anechoic 0 Wider
1 Isoechoic 1 Lobulated 2 Macrocalcications 1
2 Hypoechoic 2 Irregular 2 Peripheral (rim)
Very hypoechoic
Low suspicion Very low
Margin (choose 1)
than tall
wide
3 Extra-
↓
suspicious
≥2.5cm FNA if ≥1.5cm
suspicion
Shape (choose 1)
0 Smooth 0 None 0
3 Ill-dened 0 Large comet tail
thyroid extension
Moderately suspicious
FNA if ≥1.5cm FNA if ≥1.0cm
Benign No nodule/size cutoff (1cm)
Echogenic foci (choose 1)
artifacts
calcications
3 Punctate echogenic
foci
Highly suspicious
FNA if ≥1.0cm FNA if ≥0.5cm
261
0
2
3
According to a study by Yoon etal. [6], the ATA guidelines were unable to clas­sify 3.4% of 1293 nodules, of which 18.2% were malignant. In 2017, the American College of Radiology (ACR) published a white paper on Thyroid Imaging, Reporting and Data System (TI-RADS), as shown in Table18.3 [7].
Bethesda System
Thyroid nodule FNA cytologic should be reported using diagnostic groups outlined in the Bethesda system or Reporting Thyroid Cytopathology (Table18.4) [8].
262
Table 18.4 Bethesda system revised in 2017 based on post-2010 date
Categories Nondiagnostic 5–10 (5–10) Repeat FNA with US Benign 0–3 (0–3) Clinical and US follow-up Atypia of undetermined signicance (AUS)/
follicular lesion of undetermined signicance (FLUS)
Follicular neoplasm/suspicious for follicular neoplasm (FN/SFN)
Suspicious for malignancy 50–75 (45–60) Lobectomy or near-total
Malignant 97–99 (94–96) Near-total thyroidectomy
*Adjusted risks if noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) was not classied as a malignancy. FNA ne-needle aspiration, US ultrasound
% Risk of malignancy (*) Usual management
10–30 (6–18) Repeat FNA, molecular
testing, or lobectomy
25–40 (10–40) Molecular testing,
lobectomy
thyroidectomy
A. W. Park et al.
Treatment
Benign Lesion
If the nodule is benign on cytology, further immediate diagnostic studies or treat­ment is not required.
Malignant Lesion
If a cytologic result is diagnostic for primary thyroid malignancy, surgery is gener­ally recommended.

Thyroid Radiofrequency Ablation

In 1990, percutaneous ethanol ablation (EA) was introduced for treating AFTNs. Although EA is very effective for cystic thyroid nodules and can achieve a volume reduction of more than 85%, it is less effective for solid nodules. It also has several limitations, such as unpredictable diffusion within the tumor, pain, and capsular brosis by leaking, making future surgery challenging.
More recently, advances in thermal ablation have allowed effective treatment of solid, benign thyroid nodules. Various energy sources are currently used in thermal ablation, including laser, radiofrequency (RF), microwave, and high-intensity focused ultrasound (HIFU). To date, radiofrequency ablation (RFA) has been the
18 Interventional Treatment ofThyroid Nodules
263
most exhaustively researched and proven therapy in terms of safety and clinical efcacy. Hereafter, RFA will be mainly described in regard to thermal ablation.
The strategy for choosing between EA and thermal ablation depends on the com­position of thyroid nodules [9]:
• Cystic nodule: EA
• Predominantly cystic nodule: EA rst or combined with thermal ablation
• Predominantly solid or solid nodule: thermal ablation
Indications
Thyroid RFA guidelines are designed to provide scientic information regarding the use of this procedure in clinical practice. Several guidelines have been published [10–17]. A systematic review of clinical practice guidelines for RFA of benign thy­roid nodules was published recently [18]. There are subtle differences between these guidelines with indications in common. According to the revised KSThR 2017 guideline [14], the indications and contraindications for treating benign thyroid nodules are as follows.
Indications
• Patients with benign thyroid nodules producing symptoms or patients with cos-
metic concerns
• Toxic or pretoxic AFTNs
Thyroid nodules should be conrmed as benign on at least two US-guided FNA or core needle biopsy (CNB) before RFA.A single benign diagnosis on FNA or CNB is sufcient when the nodule has the US features highly specic for benignity and AFTN.In addition, caution should be taken in the use of RFA in pregnant women, patients with serious heart problems, and those with pre-existing contralat­eral vocal cord palsy.
Contraindications
• Follicular neoplasm or malignancy on FNA or CNB
• A nodule with US criteria suggesting malignancy, despite FNA or CNB results
• Cystic and predominantly cystic thyroid nodules, in which EA has been sug-
gested as a rst-line treatment
264
A. W. Park et al.
Anatomy
For a safe and effective procedure, knowledge of neck anatomy, particularly that of the nerves, vessels, and other critical structures, is essential. It is of utmost impor­tance to understand US-based thyroidal and perithyroidal anatomy.
The Thyroid Gland
The thyroid gland is a buttery-shaped midline structure lying anterior and lateral to the trachea in the visceral space of the infrahyoid neck. In adults, each lobe is about 40–60mm in length, 10–20mm in width, and 13–18mm in thickness. The right and left lobes are connected by the isthmus in 2–3mm in thickness. The limits of normal thyroid volume are 10–15mL for adult females and 12–18mL for males [19]. The trachea, esophagus, thyroid gland, and infrahyoid muscles are enclosed by the pretracheal fascia (Fig.18.1). The pretracheal layer of fascia is situated in the anterior neck, spanning between the hyoid bone superiorly and the thorax inferiorly, where it fuses with the pericardium (Fig.18.2).
Fig. 18.1 Cross-sectional diagram of the neck with three layers of the deep cervical fascia; T trachea, E esophagus. (With permissions from Park [20])
T
E
Investing fascia
Pretracheal fascia
Prevertebral fascia
18 Interventional Treatment ofThyroid Nodules
265
Fig. 18.2 Sagittal view of the pretracheal fascia; T thyroid gland. (With permissions from Park [20])
Anterior
Pretracheal fascia
Posterior
Hyoid bone
Thyroid cartilage
Cricoid cartilage
T
Tracheal rings
Fibrous pericardium
The false thyroid capsule (also known as the surgical capsule or perithyroidal sheath) has a thin layer of fascia enveloping the thyroid gland, which needs to be dissected away from the thyroid during surgery. Most anatomists and surgeons have described it as a thin capsule deriving from the pretracheal fascia similar to a mes­entery in the abdomen. The true capsule is formed by condensation of the brous stroma of the gland.
The space between the false capsule and the true capsule is a potential space to inject a local anesthetic. For RFA of benign thyroid nodules, perithyroidal lidocaine injection is recommended as a local anesthesia technique [14]. During perithyroidal lidocaine injection, the needle tip should be positioned close to the thyroid gland. Initially, injecting a small amount of lidocaine will create a space between the two capsules. Additional administration of lidocaine injection will dissect the space (Fig.18.3) and propagate the anesthetic along the posterolateral margin of the thy­roid gland.
Vessels
The arteries and veins of the thyroid gland are shown in Table18.5. The common carotid artery (CCA) and internal jugular vein (IJV) are located in the posterolat-
eral aspect of the thyroid gland. The superior thyroidal artery runs supercially on
266
a b
False capsule
T
Perithyroid space
A. W. Park et al.
Tr ue capsule
Fig. 18.3 (a) Perithyroidal hydrodissection along the pretracheal fascia; T trachea, E esophagus (With permissions from Park [20]). (b) Lidocaine injection in the right perithyroidal space; solid white arrow, needle tip; IJV internal jugular vein, CCA common carotid artery
Table 18.5 The vessels of the thyroid gland
Artery Vein Superior thyroid Superior thyroid
Inferior thyroid Inferior thyroid Thyroid ima (directly from aortic arch) Anterior jugular vein
E
Middle thyroid
the anterior border of the thyroid gland. This artery runs closely and anterolaterally to the external branch of the superior laryngeal nerve (SLN). The inferior thyroidal artery enters the tracheoesophageal groove in a plane posterior to the carotid space, and branches thereof penetrate the posterior aspect of the lateral thyroid lobe (Fig.18.4).
The anterior jugular vein begins near the hyoid bone at the conuence of several supercial veins arising from the submaxillary region (Fig.18.5). The vein descends along the anterior border of the sternocleidomastoid muscle and passes beneath that muscle to drain into the external jugular vein in the lower part of the neck. This vein is located along the approach route (in front of the isthmus) of the electrode. Although injury to the anterior jugular vein can be easily controlled by simple man­ual compression, it can disturb the procedure due to persistent oozing.
Muscles
The neck is a cage-like structure encaged by muscles, classied into three groups (Table18.6). When visualized on US, the neck muscles act as important landmarks for the identication of the nerves (Figs.18.6 and 18.7).
18 Interventional Treatment ofThyroid Nodules
267
Superior thyroid artery
Inferior thyroid artery
Thyroid Ima artery
Fig. 18.4 The vessels of the thyroid gland; blue, vein; red, artery. (With permissions from Park [20])
Fig. 18.5 The location of the paired anterior jugular veins. (With permissions from Park [20])
Superior thyroid vein
Middle thyroid vein
Inferior thyroid vein
Anterior jugular vein
External jugular vein
Nerves
Ultrasonographic visibility of the nerve depends on the size of the nerve, the equip­ment used, and the location in the neck. With high-frequency electrodes (>10–12MHz), the nerve has a honeycomb-like appearance or displays a reticular
268
Table 18.6 The muscles surrounding the thyroid gland
Anterior Lateral Posterior Strap muscles: four pairs of muscles:
Thyrohyoid Omohyoid Sternohyoid Sternothyroid
Fig. 18.6 Relationship of the neck muscles to nerves; ASM anterior scalene muscle, LCM longus colli muscle, MSM middle scalene muscle, SCM sternocleidomastoid muscle, SHM sternothyroid muscle, STM sternothyroid muscle, OHM omohyoid muscle, PM platysma muscle. (With permis­sions from Park [20])
Sternocleidomastoid muscle Scalene muscles Anterior Middle Posterior Levator scapulae muscle Trapezius
A. W. Park et al.
Longus colli muscle Longus capitis muscle
Fig. 18.7 Transverse US scan of the thyroid gland; SK skin, FC fascia cervicalis, SHM sternohy­oid muscle, STM sternothyroid muscle, SCM sternocleidomastoid muscle, OHM omohyoid mus­cle, ISM isthmus, TH trachea, RTL right thyroid lobe, LTL left thyroid lobe, IJV internal jugular vein, CCA common carotid artery, LCM longus colli muscle. (With permissions from Park [20])